CO6290791A2 - Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws - Google Patents
Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmwsInfo
- Publication number
- CO6290791A2 CO6290791A2 CO10074488A CO10074488A CO6290791A2 CO 6290791 A2 CO6290791 A2 CO 6290791A2 CO 10074488 A CO10074488 A CO 10074488A CO 10074488 A CO10074488 A CO 10074488A CO 6290791 A2 CO6290791 A2 CO 6290791A2
- Authority
- CO
- Colombia
- Prior art keywords
- seq
- nos
- virus
- porcine circovirus
- circus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1.- Un circovirus porcino aislado cuyo genoma comprende la molécula de ácido nucleico de SEQ ID NOs: 1 o 2, o cuyo genoma comprende una molécula de ácido nucleico que tiene por lo menos 95% de homología de secuencia de SEQ ID NOs: 1 o 2.2.- El circovirus porcino aislado de la Reivindicación 1, cuyo genoma comprende la molécula de ácido nucleico de SEQ ID Nos: 1 o 2.3.- El circovirus porcino aislado de las Reivindicaciones 1 o 2, que es un circovirus porcino tipo 2B.4.- El circovirus porcino aislado de la Reivindicación 3, que tiene una proteína ORF2 con por lo menos 92 % de identidad de secuencia de SEQ ID NOs: 3 o 4.5.- El circovirus porcino aislado de la Reivindicación 2, en donde el ácido nucleico que codifica la proteína comprende los residuos 1033-1734 de SEQ ID NOs: 5 o 6.6.- Una molécula de ácido nucleico aislada que codifica un circovirus porcino patogénico tipo 2B, o que codifica por lo menos una proteína de dicho circovirus, en donde la molécula de ácido nucleico comprende la secuencia de nucleótido de cualquiera de las SEQ ID NOs: 1, 2, 5 o 6 o una secuencia de nucleótido que tiene por lo menos 95% de homología de secuencia para cualquiera de las SEQ ID NOs: 1, 2, 5 o 6.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1589407P | 2007-12-21 | 2007-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6290791A2 true CO6290791A2 (es) | 2011-06-20 |
Family
ID=40436491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10074488A CO6290791A2 (es) | 2007-12-21 | 2010-06-21 | Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20090162398A1 (es) |
| EP (1) | EP2225367A1 (es) |
| JP (2) | JP2011507522A (es) |
| KR (1) | KR20100094587A (es) |
| CN (1) | CN101932700A (es) |
| AR (1) | AR069882A1 (es) |
| AU (1) | AU2008343172B2 (es) |
| BR (1) | BRPI0821286A8 (es) |
| CA (1) | CA2710247C (es) |
| CL (1) | CL2008003813A1 (es) |
| CO (1) | CO6290791A2 (es) |
| ME (1) | ME01156B (es) |
| NZ (1) | NZ586238A (es) |
| RU (1) | RU2493254C9 (es) |
| UA (1) | UA99495C2 (es) |
| WO (1) | WO2009085912A1 (es) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
| WO2011048215A1 (en) * | 2009-10-22 | 2011-04-28 | Universität Leipzig | Detection of a circovirus in calves suffering from bovine neonatal pancytopenia |
| WO2011091389A2 (en) * | 2010-01-25 | 2011-07-28 | Blood Systems, Inc. | Cyclovirus and method of use |
| CN102971425A (zh) | 2010-03-16 | 2013-03-13 | 弗吉尼亚科技知识产权有限公司 | 活的减毒嵌合猪圆环病毒疫苗 |
| KR101675185B1 (ko) * | 2010-07-08 | 2016-11-10 | 유나이티드 바이오메디칼 인크. | 디자이너(designer) 펩티드-기반 pcv2 백신 |
| CN101920012B (zh) * | 2010-07-22 | 2012-12-12 | 普莱柯生物工程股份有限公司 | 利用家蚕生物反应器生产猪圆环病毒2型重组衣壳蛋白亚单位疫苗的方法及其产品 |
| KR101030792B1 (ko) * | 2010-09-16 | 2011-04-27 | 주식회사 코미팜 | 돼지 써코바이러스２(ｐｃｖ２) 유전자의 표면발현용 벡터 및 이로 형질전환된 살모넬라 백신 균주 |
| CN102199571B (zh) * | 2011-04-06 | 2013-07-31 | 华中农业大学 | 一种表达猪2型圆环病毒orf2基因片段的重组支气管败血波氏杆菌株、疫苗及应用 |
| CN102988978B (zh) * | 2011-08-01 | 2016-02-03 | 普莱柯生物工程股份有限公司 | 含有猪圆环病毒2型抗原与副猪嗜血杆菌抗原的疫苗组合物及其制备方法与应用 |
| HUP1100470A2 (en) | 2011-08-30 | 2013-03-28 | Mezoegazdasagi Biotechnologiai Kutatokoezpont | Nanoparticle-based veterinary vaccine |
| EP2564869A1 (en) | 2011-09-02 | 2013-03-06 | Ceva Sante Animale | Synthetic capsid proteins and uses thereof |
| CN103083655B (zh) * | 2011-11-02 | 2015-08-26 | 普莱柯生物工程股份有限公司 | 预防和治疗猪圆环病毒2型、副猪嗜血杆菌和猪肺炎支原体感染的疫苗组合物及其制备方法 |
| CN103033622B (zh) * | 2011-12-26 | 2015-03-25 | 武汉中博生物股份有限公司 | 猪圆环病毒2型elisa抗原检测试剂盒及其制备方法和其应用 |
| CN102517331A (zh) * | 2011-12-26 | 2012-06-27 | 武汉中博生物股份有限公司 | 一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用 |
| US9474692B2 (en) | 2012-01-13 | 2016-10-25 | Boehringer Ingelheim Vetmedica Gmbh | Kit for the preparation of a vaccinating agent |
| US9982239B2 (en) | 2012-06-12 | 2018-05-29 | Alternative Gene Expression S.L. | Baculoviral DNA elements for the expression of recombinant proteins in a host cell |
| EP2884997B1 (en) | 2012-08-17 | 2020-01-22 | Intervet International B.V. | An immunogenic composition of killed leptospira bacteria |
| CN102824634B (zh) * | 2012-09-14 | 2014-03-19 | 范红结 | 表达猪圆环病毒2型Cap蛋白的重组猪痘病毒载体疫苗及其制备方法 |
| CN103920146A (zh) * | 2013-01-14 | 2014-07-16 | 普莱柯生物工程股份有限公司 | 猪圆环病毒ⅱ型与猪伪狂犬病二联疫苗及其制备方法和应用 |
| BR102013001893B1 (pt) * | 2013-01-25 | 2022-01-25 | Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig | Antígenos recombinantes do porcine circovirus 2 (pcv-2) para formulações vacinais, kit de diagnóstico e uso |
| EP2789346A1 (en) | 2013-04-11 | 2014-10-15 | CEVA Santé Animale SA | Fusion polypeptides and vaccines |
| CN103275938B (zh) * | 2013-05-07 | 2015-02-25 | 上海市农业科学院 | 猪圆环病毒弱毒疫苗株的制备方法 |
| PL2994162T3 (pl) | 2013-05-08 | 2021-10-18 | Pharmgate Biologics Inc. | Szczepionka przeciwko pcv2 i mykoplazmie |
| EP4176899A1 (en) | 2013-08-23 | 2023-05-10 | Boehringer Ingelheim Animal Health USA Inc. | Porcine circovirus type 2 (pcv2) subunit vaccine |
| CA2925281C (en) | 2013-09-25 | 2022-05-03 | Zoetis Services Llc | Pcv2b divergent vaccine composition and methods of use |
| ES2778425T3 (es) | 2013-10-02 | 2020-08-10 | Boehringer Ingelheim Animal Health Usa Inc | Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta |
| CN104248759B (zh) * | 2013-11-19 | 2017-05-10 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其制备方法和应用 |
| CN104250640A (zh) | 2014-08-22 | 2014-12-31 | 普莱柯生物工程股份有限公司 | 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
| CN105709220B (zh) * | 2014-12-03 | 2020-03-31 | 普莱柯生物工程股份有限公司 | 用于猪圆环病毒与猪流感的疫苗组合物及制备方法和应用 |
| EP3034609A1 (en) | 2014-12-19 | 2016-06-22 | Ceva Sante Animale | Recombinant swinepox virus and vaccines |
| CN104984335A (zh) * | 2015-07-14 | 2015-10-21 | 浙江诺倍威生物技术有限公司 | 猪圆环病毒双亚型orf2共表达载体构建及疫苗制备 |
| WO2017066772A1 (en) * | 2015-10-16 | 2017-04-20 | Kansas State University Research Foundation | Porcine circovirus type 3 immunogenic compositions and methods of making and using the same |
| SG11201805379QA (en) * | 2015-12-28 | 2018-07-30 | Merial Inc | M hyo multivalent vaccine and uses thereof |
| CN105785037B (zh) * | 2016-03-30 | 2017-09-19 | 中国农业科学院兰州兽医研究所 | 猪圆环病毒2型抗体快速检测层析试纸条及制备方法 |
| EP3254692A1 (en) | 2016-06-10 | 2017-12-13 | Ceva Sante Animale | Multivalent recombinant spv |
| CN106435016B (zh) * | 2016-08-30 | 2019-07-26 | 中国农业科学院兰州兽医研究所 | 一种快速显色一步法检测猪圆环病毒2型的lamp试剂盒 |
| CN107937354A (zh) * | 2017-11-10 | 2018-04-20 | 南京天邦生物科技有限公司 | 2型猪圆环病毒及其应用 |
| WO2019110822A1 (en) | 2017-12-08 | 2019-06-13 | Ceva Sante Animale | Recombinant swinepox virus and vaccines |
| KR102133632B1 (ko) * | 2018-03-29 | 2020-07-13 | 충남대학교산학협력단 | 재조합 돼지 써코바이러스 및 이를 포함하는 돼지 써코바이러스 감염 질환의 예방용 백신 조성물 |
| MX2020013484A (es) | 2018-06-11 | 2021-05-27 | Ceva Sante Animale | Vacunacion contra circovirus porcinos. |
| CN109381696A (zh) * | 2018-08-27 | 2019-02-26 | 长沙创西生物科技有限公司 | 一种用于防治猪圆环病毒病的缓释微囊的制备方法 |
| CN111088396A (zh) * | 2019-11-14 | 2020-05-01 | 河南科技学院 | 一种同时检测副猪嗜血杆菌、猪细小病毒、猪圆环病毒2型的三重实时荧光pcr方法 |
| RU2747468C1 (ru) * | 2020-06-23 | 2021-05-05 | Федеральное Казенное Предприятие "Щелковский Биокомбинат" | Способ получения вакцины против цирковируса свиней (варианты) |
| CN113907044A (zh) * | 2021-11-09 | 2022-01-11 | 福建省连江县刘氏兔业养殖场 | 一种抗病猪品系的培育方法及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0138854B1 (en) * | 1983-03-08 | 1992-11-04 | Chiron Mimotopes Pty. Ltd. | Antigenically active amino acid sequences |
| US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
| US5238662A (en) * | 1987-07-31 | 1993-08-24 | Chevron Research Company | Processes for recovering precious metals |
| US5147966A (en) * | 1990-07-31 | 1992-09-15 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Polyimide molding powder, coating, adhesive and matrix resin |
| FR2769322B1 (fr) * | 1997-10-03 | 2002-03-08 | Merial Sas | Nouveaux circovirus porcins, vaccins et reactifs de diagnostic |
| US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
| UA78180C2 (uk) * | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
| US20040062775A1 (en) * | 1997-12-05 | 2004-04-01 | Agence Francaise De Securite Sanitaire Des Aliments | Circovirus sequences associated with piglet weight loss disease (PWD) |
| FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| US6287856B1 (en) * | 1998-03-13 | 2001-09-11 | University Of Georgia Research Foundation, Inc. | Vaccines against circovirus infections |
| PT1379671E (pt) * | 2001-03-27 | 2009-07-20 | Univ Saskatchewan | Métodos de cultura de circovírus |
| US20030096377A1 (en) * | 2001-06-28 | 2003-05-22 | Virginia Tech Intellectual Properties, Inc. | Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2 |
| US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| US7276353B2 (en) * | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| PT2371383E (pt) * | 2005-12-29 | 2015-11-24 | Boehringer Ingelheim Vetmed | Utilização de uma composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos |
-
2008
- 2008-12-18 KR KR1020107016228A patent/KR20100094587A/ko not_active Application Discontinuation
- 2008-12-18 ME MEP-2010-93A patent/ME01156B/me unknown
- 2008-12-18 US US12/338,226 patent/US20090162398A1/en not_active Abandoned
- 2008-12-18 CA CA2710247A patent/CA2710247C/en active Active
- 2008-12-18 BR BRPI0821286A patent/BRPI0821286A8/pt not_active Application Discontinuation
- 2008-12-18 RU RU2010124791/10A patent/RU2493254C9/ru active
- 2008-12-18 NZ NZ586238A patent/NZ586238A/xx unknown
- 2008-12-18 WO PCT/US2008/087361 patent/WO2009085912A1/en active Application Filing
- 2008-12-18 JP JP2010539780A patent/JP2011507522A/ja active Pending
- 2008-12-18 CL CL2008003813A patent/CL2008003813A1/es unknown
- 2008-12-18 UA UAA201007554A patent/UA99495C2/ru unknown
- 2008-12-18 EP EP08867869A patent/EP2225367A1/en not_active Ceased
- 2008-12-18 AU AU2008343172A patent/AU2008343172B2/en not_active Withdrawn - After Issue
- 2008-12-18 CN CN2008801255848A patent/CN101932700A/zh active Pending
- 2008-12-19 AR ARP080105635A patent/AR069882A1/es not_active Application Discontinuation
-
2010
- 2010-06-21 CO CO10074488A patent/CO6290791A2/es not_active Application Discontinuation
-
2011
- 2011-03-09 US US13/043,853 patent/US20110305725A1/en not_active Abandoned
-
2016
- 2016-09-29 JP JP2016191501A patent/JP2017060473A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0821286A2 (pt) | 2014-10-14 |
| JP2011507522A (ja) | 2011-03-10 |
| CN101932700A (zh) | 2010-12-29 |
| US20110305725A1 (en) | 2011-12-15 |
| AU2008343172B2 (en) | 2015-02-19 |
| JP2017060473A (ja) | 2017-03-30 |
| RU2493254C9 (ru) | 2013-12-20 |
| KR20100094587A (ko) | 2010-08-26 |
| AR069882A1 (es) | 2010-02-24 |
| BRPI0821286A8 (pt) | 2017-08-15 |
| RU2010124791A (ru) | 2012-01-27 |
| RU2493254C2 (ru) | 2013-09-20 |
| US20090162398A1 (en) | 2009-06-25 |
| WO2009085912A1 (en) | 2009-07-09 |
| ME01156B (me) | 2013-03-20 |
| NZ586238A (en) | 2012-10-26 |
| EP2225367A1 (en) | 2010-09-08 |
| UA99495C2 (ru) | 2012-08-27 |
| CA2710247C (en) | 2014-02-18 |
| AU2008343172A1 (en) | 2009-07-09 |
| CL2008003813A1 (es) | 2009-03-20 |
| CA2710247A1 (en) | 2009-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6290791A2 (es) | Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws | |
| CO2020004738A2 (es) | Variantes de cápsides de virus adenoasociados y métodos de uso de estas | |
| CO2021010088A2 (es) | Construcciones de terapia génica para el tratamiento de la enfermedad de wilson | |
| AR065076A1 (es) | Vacuna contra el papilomavirus | |
| AR074678A1 (es) | Metodos y composiciones basados en pcv2 (circovirus porcino de tipo 2) para el tratamiento de cerdos | |
| AR083839A1 (es) | Virus del sindrome reproductivo y respiratorio porcino (prrs) de los estados unidos y sus usos | |
| MX2013010620A (es) | Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo. | |
| AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
| BR112016006192A2 (pt) | composição de vacina de divergente de pcv2b e métodos de uso | |
| CL2012000447A1 (es) | Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica. | |
| UY32274A (es) | Pestivirus quimericos | |
| PE20091355A1 (es) | Paramixovirus oncoliticos atenuados que codifican citoquinas de aves | |
| CO2018010874A2 (es) | Vacuna de virus de zika atenuado vivo | |
| MX2018004016A (es) | Vacunas de particulas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos. | |
| CO2019010062A2 (es) | Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens | |
| CL2013001877A1 (es) | Composicion inmunogenica que comprende un virus de diarrea viral bovina tipo 1b vivo modificado y un portador veterinario aceptable; vacuna que la comprende; y su uso para prevenir, tratar, manejar o aliviar uno o mas sintomas de una enfermedad causada por pestivirus. | |
| AR075932A1 (es) | Proteasa coagulante de leche de tipo mejorado derivada del microorganismo rhizomucor sp | |
| CO7461133A2 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
| CO2017001614A2 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
| AR124461A1 (es) | VACUNA BASADA EN AAV5 PARA LA INDUCCIÓN DE INMUNIDAD ESPECÍFICA CONTRA EL SARS-CoV-2 Y/O LA PREVENCIÓN DE LA INFECCIÓN POR CORONAVIRUS RELACIONADA CON EL SARS-CoV-2 | |
| CL2021003211A1 (es) | Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018) | |
| BRPI0920622A8 (pt) | vacina contra o vírus da doença equina africana | |
| AR103427A1 (es) | Vacuna contra la fiebre aftosa | |
| CO6541529A2 (es) | Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos | |
| CL2021002582A1 (es) | Vacunas contra el circovirus porcino tipo 3 (pcv3), su producción y usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |